| Product Code: ETC13139517 | Publication Date: Apr 2025 | Product Type: Market Research Report | |
| Publisher: 6Wresearch | No. of Pages: 150 | No. of Figures: 55 | No. of Tables: 32 |
North America Monogenic Disease Testing Market |
1 Executive Summary |
2 Introduction |
2.1 Key Highlights of the Report |
2.2 Report Description |
2.3 Market Scope & Segmentation |
2.4 Research Methodology |
2.5 Assumptions |
3 North America Monogenic Disease Testing Market Overview |
3.1 North America Regional Macro Economic Indicators |
3.2 North America Monogenic Disease Testing Market Revenues & Volume, 2021 & 2031F |
3.3 North America Monogenic Disease Testing Market - Industry Life Cycle |
3.4 North America Monogenic Disease Testing Market - Porter's Five Forces |
3.5 North America Monogenic Disease Testing Market Revenues & Volume Share, By Countries, 2021 & 2031F |
3.6 North America Monogenic Disease Testing Market Revenues & Volume Share, By Test Type, 2021 & 2031F |
3.7 North America Monogenic Disease Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
3.8 North America Monogenic Disease Testing Market Revenues & Volume Share, By End use, 2021 & 2031F |
4 North America Monogenic Disease Testing Market Dynamics |
4.1 Impact Analysis |
4.2 Market Drivers |
4.3 Market Restraints |
5 North America Monogenic Disease Testing Market Trends |
6 North America Monogenic Disease Testing Market, 2021 - 2031 |
6.1 North America Monogenic Disease Testing Market, Revenues & Volume, By Test Type, 2021 - 2031 |
6.1.1 Overview & Analysis |
6.1.2 North America Monogenic Disease Testing Market, Revenues & Volume, By Carrier Testing, 2021 - 2031 |
6.1.3 North America Monogenic Disease Testing Market, Revenues & Volume, By Diagnostic Testing, 2021 - 2031 |
6.1.4 North America Monogenic Disease Testing Market, Revenues & Volume, By New-Born Screening, 2021 - 2031 |
6.1.5 North America Monogenic Disease Testing Market, Revenues & Volume, By Predictive and Pre-Symptomatic Testing, 2021 - 2031 |
6.1.6 North America Monogenic Disease Testing Market, Revenues & Volume, By Prenatal Testing, 2021 - 2031 |
6.2 North America Monogenic Disease Testing Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
6.2.1 Overview & Analysis |
6.2.2 North America Monogenic Disease Testing Market, Revenues & Volume, By Cystic fibrosis, 2021 - 2031 |
6.2.3 North America Monogenic Disease Testing Market, Revenues & Volume, By Sickle Cell Anemia, 2021 - 2031 |
6.2.4 North America Monogenic Disease Testing Market, Revenues & Volume, By Severe Combined Immunodeficiency (SCID), 2021 - 2031 |
6.2.5 North America Monogenic Disease Testing Market, Revenues & Volume, By Tay-Sachs Disorder, 2021 - 2031 |
6.2.6 North America Monogenic Disease Testing Market, Revenues & Volume, By Polycystic Kidney Disorder, 2021 - 2031 |
6.2.7 North America Monogenic Disease Testing Market, Revenues & Volume, By Others, 2021 - 2031 |
6.3 North America Monogenic Disease Testing Market, Revenues & Volume, By End use, 2021 - 2031 |
6.3.1 Overview & Analysis |
6.3.2 North America Monogenic Disease Testing Market, Revenues & Volume, By Hospitals, 2021 - 2031 |
6.3.3 North America Monogenic Disease Testing Market, Revenues & Volume, By Ambulatory Surgical Centers, 2021 - 2031 |
6.3.4 North America Monogenic Disease Testing Market, Revenues & Volume, By Specialized Clinics, 2021 - 2031 |
7 North America Monogenic Disease Testing Market, By Countries, 2021 - 2031 |
7.1 Overview & Analysis |
7.2 North America Monogenic Disease Testing Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.1 United States (US) Monogenic Disease Testing Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.2 Canada Monogenic Disease Testing Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.2.3 Rest of North America Monogenic Disease Testing Market, Revenues & Volume, By Test Type, 2021 - 2031 |
7.3 North America Monogenic Disease Testing Market Revenues & Volume Share, By Disease Type, 2021 & 2031F |
7.3.1 United States (US) Monogenic Disease Testing Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.2 Canada Monogenic Disease Testing Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.3.3 Rest of North America Monogenic Disease Testing Market, Revenues & Volume, By Disease Type, 2021 - 2031 |
7.4 North America Monogenic Disease Testing Market, Revenues & Volume, By End use, 2021 - 2031 |
7.4.1 United States (US) Monogenic Disease Testing Market, Revenues & Volume, By End use, 2021 - 2031 |
7.4.2 Canada Monogenic Disease Testing Market, Revenues & Volume, By End use, 2021 - 2031 |
7.4.3 Rest of North America Monogenic Disease Testing Market, Revenues & Volume, By End use, 2021 - 2031 |
8 North America Monogenic Disease Testing Market Key Performance Indicators |
9 North America Monogenic Disease Testing Market - Export/Import By Countries Assessment |
10 North America Monogenic Disease Testing Market - Opportunity Assessment |
10.1 North America Monogenic Disease Testing Market Opportunity Assessment, By Countries, 2021 & 2031F |
10.2 North America Monogenic Disease Testing Market Opportunity Assessment, By Test Type, 2021 & 2031F |
10.3 North America Monogenic Disease Testing Market Opportunity Assessment, By Disease Type, 2021 & 2031F |
10.4 North America Monogenic Disease Testing Market Opportunity Assessment, By End use, 2021 & 2031F |
11 North America Monogenic Disease Testing Market - Competitive Landscape |
11.1 North America Monogenic Disease Testing Market Revenue Share, By Companies, 2022 |
11.2 North America Monogenic Disease Testing Market Competitive Benchmarking, By Operating and Technical Parameters |
12 Top 10 Company Profiles |
13 Recommendations |
14 Disclaimer |
Export potential enables firms to identify high-growth global markets with greater confidence by combining advanced trade intelligence with a structured quantitative methodology. The framework analyzes emerging demand trends and country-level import patterns while integrating macroeconomic and trade datasets such as GDP and population forecasts, bilateral import–export flows, tariff structures, elasticity differentials between developed and developing economies, geographic distance, and import demand projections. Using weighted trade values from 2020–2024 as the base period to project country-to-country export potential for 2030, these inputs are operationalized through calculated drivers such as gravity model parameters, tariff impact factors, and projected GDP per-capita growth. Through an analysis of hidden potentials, demand hotspots, and market conditions that are most favorable to success, this method enables firms to focus on target countries, maximize returns, and global expansion with data, backed by accuracy.
By factoring in the projected importer demand gap that is currently unmet and could be potential opportunity, it identifies the potential for the Exporter (Country) among 190 countries, against the general trade analysis, which identifies the biggest importer or exporter.
To discover high-growth global markets and optimize your business strategy:
Click Here